Peripheral LPS administrations up-regulate Fas and FasL on brain microglial cells: A brain protective or pathogenic event?

Journal of Neuroimmunology

Volumn 124, Issue 1-2, 2002, Pages 45-53

  Terrazzino, Salvatore ^a   Bauleo, Alessia ^a   Baldan, Andrea ^a   Leon, Alberta ^a  

^a Research and Innovation R and I Company   (Italy)

Author keywords

Apoptosis; Brain inflammation; Fas; FasL; Microglia; Systemic LPS

Indexed keywords

FAS ANTIGEN; FAS LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MICROGLIA; MOUSE; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NICK END LABELING; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD95; BRAIN; FAS LIGAND PROTEIN; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; LECTINS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICROGLIA; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAINING AND LABELING; UP-REGULATION;

EID: 0036198649     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00013-9     Document Type: Article

References (42)

1. Inflammation and Alzheimer's disease
2. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro
3. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
4. Reactive astrocytes up-regulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration
5. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat
6. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia
7. Cell death during autoimmune demyelination: Effector but not target cells are eliminated by apoptosis
8. Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: Induction of caspase-dependent cell death and activation of NF-kappaB
9. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons
10. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages
11. Fas and FasL expression in Huntington's disease and Parkinson's disease
12. Microglia as mediators of inflammatory and degenerative diseases
13. Fas ligand-induced apoptosis as a mechanism of immune privilege
14. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy
15. Therapeutic approaches to the treatment of neuroinflammatory diseases
16. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction
17. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis
18. Toll-like receptor 4: The missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components
19. Differential regulation and function of Fas expression on glial cells
20. Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord
21. CD95 ligand (FasL/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
22. Fas receptor and neuronal cell death after spinal cord ischemia
23. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
24. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia
25. Lipopolysaccharide-induced fever is dissociated from apoptotic cell death in the rat brain
26. Immune privilege or inflammation? Insights into the Fas ligand enigma
27. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide
28. Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia
29. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
30. Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease
31. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis
32. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
33. Dynamics of microglial activation: A confocal time-lapse analysis in hippocampal slices
34. Inflammation and glial responses in ischemic brain lesions
35. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
36. Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines
37. Induction of tolerance against ischemia/reperfusion injury in the rat brain by preconditioning with the endotoxin analog diphosphoryl lipid A
38. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
39. Targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
40. Immune regulation within the central nervous system
41. Molecular mechanisms of microglial activation
42. Presence and significance of CD-95 (Fas/APO1) expression after spinal cord injury